Delhi left with 2-3 days' vaccine stock for 45+, key workers: Atishi

AAP leader Atishi Thursday said Delhi is left with just two-three days' stock of coronavirus vaccines for those above 45, and key workers.

Atishi Marlena
Atishi Marlena
Press Trust of India New Delhi
2 min read Last Updated : May 13 2021 | 6:51 PM IST

AAP leader Atishi Thursday said Delhi is left with just two-three days' stock of coronavirus vaccines for those above 45, and key workers.

For the 18-44 age group, the capital has eight days of Covishield doses available, she said.

"Delhi currently has three days of Covaxin and two days of Covishield stock for those above 45, and healthcare and frontline workers. We request the government to make more doses available for this category," she said.

Delhi has so far got 43.20 lakh doses for 45-plus, and healthcare and frontline workers, of which 40.29 lakh have been utilised, Atishi said.

The city has received 8.17 lakh doses of coronavirus vaccines for the 18-44 category. Of this, 4.27 lakh have been utilised. The remaining doses, primarily Covishield, can last up to eight days, she said.

The city has already run out of Covaxin stock for 18+ category. Therefore, most of the centres administering the Bharat Biotech vaccine have been temporarily shut till further orders.

The AAP leader said 74,448 people were vaccinated in Delhi on Wednesday.

Dispensaries conduct routine immunisation of children on Wednesdays and Fridays. So, there were fewer vaccination centres on May 12, she said.

A total of 41.64 lakh doses have been administered to beneficiaries across all categories in Delhi since the inoculation drive started on January 16, according to the bulletin.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: May 13 2021 | 6:49 PM IST

Next Story